Digital Transformation

Digital Clinical Trials

Our Digital Clinical Trials service helps pharmaceutical companies and CROs design and implement decentralized clinical trials (DCTs). We provide DCT strategy, technology platform selection, vendor evaluation, and implementation support. From remote patient monitoring to virtual visits, we help you modernize trial execution for faster, cheaper, more patient-centric studies.

Key Benefits

How our digital clinical trials service delivers value to your organization.

DCT Strategy

Decentralized trial strategy including hybrid design, site selection, and patient journey optimization.

Technology Selection

DCT technology platform selection including eConsent, remote monitoring, telehealth, and eCOA.

Vendor Evaluation

Comprehensive evaluation of DCT vendors including science 37, Medable, Thread, and others.

Regulatory Compliance

Regulatory strategy for DCTs including FDA, EMA, and ICH compliance for decentralized elements.

What You Get

Comprehensive deliverables that provide actionable intelligence for your team.

DCT strategy with hybrid trial design recommendations
Technology platform evaluation with selection recommendations
Vendor evaluation matrix with capability and cost comparison
Regulatory compliance plan for DCT elements
Implementation roadmap with pilot trial design
Patient engagement strategy for digital trials

Our Process

A structured methodology that delivers results in four phases.

01

Assessment

Assess trial requirements, patient population, and site capabilities for DCT suitability.

02

Strategy

Develop DCT strategy including trial design, technology needs, and vendor requirements.

03

Technology Selection

Evaluate and select DCT technology platforms and vendors.

04

Implementation

Support DCT implementation including pilot trial, training, and scale-up.

Frequently Asked Questions

What is a decentralized clinical trial?

A decentralized clinical trial (DCT) uses digital technology to conduct some or all trial activities remotely, reducing or eliminating the need for in-person site visits. Hybrid DCTs combine remote and in-person elements.

Which therapeutic areas are best suited for DCTs?

DCTs work well for chronic diseases (diabetes, cardiovascular), dermatology, mental health, and rare diseases. We assess suitability based on required procedures, monitoring needs, and patient population.

Can DCTs reduce trial costs?

Yes, DCTs can reduce costs by 20-50% through reduced site visits, faster recruitment, lower site overhead, and improved patient retention. We build detailed cost models for each trial.

Ready to Get Started?

Connect with our team to discuss how our digital clinical trials service can support your goals.

Schedule a Consultation